Form4insider filings, from the source

SEC Form 4 · accession 0001127602-15-026150

PALL CORP · PLL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Egholm
Officer — President, BioPharmaceuticals
Period of report
Aug 31, 2015
Accepted (ET)
Aug 31, 2015 · 1:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000075829

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Aug 31, 2015D9,201$127.20D0D
Common StockF2Aug 31, 2015D12,822—D0D
Common StockF3Aug 31, 2015D19,399$127.20D0D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F4$55.67Aug 31, 2015D653D—Jul 13, 2018Common Stock6530D
Employee Stock Option (Right to Buy)F5$59.75Aug 31, 2015D2,408D—Jan 18, 2019Common Stock2,4080D
Employee Stock Option (Right to Buy)F6$64.80Aug 31, 2015D8,148D—Jan 16, 2020Common Stock8,1480D
Employee Stock Option (Right to Buy)F7$82.47Aug 31, 2015D9,969D—Dec 11, 2020Common Stock9,9690D
Employee Stock Option (Right to Buy)F8$94.53Aug 31, 2015D11,268D—Dec 10, 2021Common Stock11,2680D

Explanation of responses